Tech Company Acquirers

Mirna Therapeutics

Mirna Therapeutics, based in Austin, bought Synlogic.

Company Overview

Contact Information

Company Background Information

Overview

Mirna Therapeutics, Inc. (NASDAQ: MIRN) is a biopharmaceutical company developing a broad pipeline of microRNA-based oncology therapeutics and is the first to establish clinical proof-of-concept for a microRNA replacement therapy for cancer.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

5/16/2017

Acquisitions By Mirna Therapeutics

Management Team

Title

Name

Email & Social

Chief Executive Officer

Paul Lammers

        

Chief Financial Officer

Alan Fuhrman

        

Chief Scientific Officer

Miguel Barbosa

        

VP - Finance

Jon Irvin

        

VP - R & D

Jay Stoudemire

        

Browse more tech company acquirers:

MIPS Technologies | Mitel Networks

Share this article

About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary